We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for patients, healthcare professionals and developers of new medicines
Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Guidance for alcohol and drug treatment services to help them get the balance right between providing remote and in-person interventions for service users.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
New 10-year plan to expand and improve the drug and alcohol workforce published.
How to use an interrupted time series to evaluate your digital health product.
Advice on best practice for reviewing individuals in substance misuse treatment.
Actions that trial sponsors should consider to build resilience into clinical trial design
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.